Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Avecho Biotechnology Limited
  6. News
  7. Summary
    AVE   AU0000047441

AVECHO BIOTECHNOLOGY LIMITED

(AVE)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Avecho Biotechnology : Secures Ethics Approval for Cannabidiol Product Test on Humans

04/12/2021 | 11:08pm EDT


ę MT Newswires 2021
All news about AVECHO BIOTECHNOLOGY LIMITED
09/15AVECHO BIOTECHNOLOGY : Begins Enrolment for Phase 1 Cannabidiol Absorption Trial
MT
09/14Avecho Commences Enrolment for Phase I Human Clinical Trial Measuring CBD Abs..
CI
08/23Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended..
CI
05/26Avecho Biotechnology to Discuss Cannabidiol Soft-Gel Product with Drug Regula..
MT
05/21AVECHO BIOTECHNOLOGY : Completes Cannabidiol Soft Gel Product Design; Shares Ral..
MT
05/20Avecho Biotechnology Limited Completes Pharmaceutical CBD Soft-Gel Product
CI
05/04Avecho Biotechnology Limited Announces Resignation of Mr. David Segal as Dire..
CI
04/12AVECHO BIOTECHNOLOGY : Secures Ethics Approval for Cannabidiol Product Test on H..
MT
04/12Avecho Biotechnology Limited Receives Ethics Approval for Cbd Human Trial
CI
02/25Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended..
CI
More news
Financials
Sales 2020 0,38 M 0,28 M 0,28 M
Net income 2020 -2,63 M -1,91 M -1,91 M
Net cash 2020 1,71 M 1,24 M 1,24 M
P/E ratio 2020 -17,1x
Yield 2020 -
Capitalization 34,9 M 25,3 M 25,3 M
EV / Sales 2019 0,75x
EV / Sales 2020 116x
Nbr of Employees 15
Free-Float 69,3%
Chart AVECHO BIOTECHNOLOGY LIMITED
Duration : Period :
Avecho Biotechnology Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVECHO BIOTECHNOLOGY LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Managers and Directors
Paul David Gavin Chief Executive & Scientific Officer
Melanie Jaye Leydin Chief Financial Officer & Secretary
Gregory Collier Executive Chairman
Roksan Libinaki Chief Operating Officer
Ross Thomas Murdoch Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
AVECHO BIOTECHNOLOGY LIMITED-34.48%25
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420